首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1907926

海洋醫藥市場：依原料、化合物類別、治療用途、研發階段、劑型類型、最終用戶、給藥方式、原料產地、應用領域及地區分類

Marine Pharmaceutical Market, By Source, By Compound Class, By Therapeutic Application, By Development Stage, By Formulation Type, By End User, By Drug Delivery Format, By Source Habitat, By Application Sector, By Geography

出版日期: 2025年12月22日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

據估計，2025 年海洋醫藥市場價值為 66.2 億美元，預計到 2032 年將達到 95 億美元，2025 年至 2032 年的複合年成長率為 5.3%。

報告內容		報告詳情
基準年：	2024	2025年市場規模：	66.2億美元
歷史數據時期：	2020年至2024年	預測期：	2025年至2032年
預測期（2025-2032年）複合年成長率：	5.30%	預計2032年價值：	95億美元

全球海洋醫藥市場是一個快速發展的領域，它利用海洋生物巨大的治療潛力來開發創新的藥物化合物和治療方法。

這個新興領域，也被稱為海洋生物技術或藍色生物技術，專注於探索海洋生態系統的生物化學多樣性，包括藻類、細菌、真菌、海綿、珊瑚和其他海洋生物，以發現具有藥用價值的新型生物活性化合物。海洋環境覆蓋了地球表面70%以上的面積，蘊藏著豐富的生物多樣性，在製藥領域具有巨大的應用潛力，尤其是在陸地資源日益枯竭的地區。

海洋棲息地獨特的環境條件，例如極端壓力、溫度波動和鹽度，促使海洋生物發展出獨特的代謝途徑，並產生具有治療潛力的特殊化合物。這些海洋來源的物質在治療多種疾病方面顯示出顯著療效，包括癌症、發炎性疾病、神經系統疾病和感染疾病。

隨著全球醫療保健產業不斷尋求創新治療方法，並面臨抗生素抗藥性和個人化醫療需求等挑戰，海洋製藥市場正吸引研究人員、製藥公司和投資者的極大關注，他們希望從海洋資源中發現突破性的治療方法。

市場動態

全球海洋來源藥物市場受到多種強大力量的驅動，這些力量正在改變製藥產業格局，並為海洋來源的治療方案創造前所未有的機會。包括癌症、心血管疾病和神經系統疾病在內的慢性病發病率不斷上升，推動了對新型高效治療方法的需求，使海洋來源藥物成為傳統陸基藥物極具前景的替代方案。

公共和私人資金對海洋生物技術研發的投入不斷增加，加速了海洋衍生化合物的發現和商業化，同時提取和純化技術的進步也使得將這些複雜的分子開發成可行的藥物變得更加可行。

然而，市場存在許多限制因素，例如海洋生物的探勘、捕撈和加工成本高成本，這會對海洋藥物的整體研發週期和商業性可行性產生重大影響。此外，海洋藥物核准的複雜性、環境問題以及永續捕撈方式的挑戰，也對市場成長構成了額外的障礙。

在實驗室環境中培養海洋生物以及擴大生產規模的技術挑戰進一步限制了市場擴張。然而，在這個充滿活力的市場格局中蘊藏著巨大的機遇，特別是透過尚未開發的深海探勘潛力以及發現具有產生創新藥物化合物潛力的極端微生物。

製藥公司與海洋研究機構之間的策略聯盟正在建立加速藥物發現的合作關係，而合成生物學和生物技術的進步正在為永續生產海洋衍生化合物開闢新途徑，最終為海洋製藥市場的顯著成長和創新奠定基礎。

本報告的主要特點

本報告對全球海洋醫藥市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和復合年成長率。
它還重點介紹了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的關鍵見解。
全球海洋製藥市場的主要企業概況、產品系列、主要亮點、財務表現和策略等參數均已列出。
本報告提供的見解將使負責人和企業經營團隊能夠就未來的產品發布、合作關係、市場擴張和行銷策略做出明智的決策。
《全球海洋製藥市場》報告面向該行業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過各種用於分析全球海洋醫藥市場的策略矩陣，更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太地區
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第14章競爭格局

PharmaMar SA
Eisai Co Ltd
Pfizer Inc
Takeda Pharmaceutical Company Limited
Seagen Inc
F Hoffmann La Roche Ltd
Astellas Pharma Inc
Jazz Pharmaceuticals plc
RemeGen Co Ltd
Gilead Sciences Inc
Waylis Therapeutics
Teva Pharmaceutical Industries Ltd
Zydus Lifesciences Ltd
Amarin Corporation plc
Merck KGaA Darmstadt Germany

第15章分析師建議

機會
分析師觀點
Coherent Opportunity Map (COM)

第16章參考文獻與分析方法

參考
分析方法
關於 Coherent Market Insights

簡介目錄

Product Code: CMI9118

Marine Pharmaceutical Market is estimated to be valued at USD 6.62 Bn in 2025 and is expected to reach USD 9.50 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.3% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 6.62 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.30%	2032 Value Projection:	USD 9.50 Bn

The global marine pharmaceutical market represents a rapidly evolving sector that harnesses the vast therapeutic potential of marine organisms to develop innovative pharmaceutical compounds and treatments.

This emerging field, also known as marine biotechnology or blue biotechnology, focuses on exploring the biochemical diversity of marine ecosystems including algae, bacteria, fungi, sponges, corals, and other sea-dwelling organisms to discover novel bioactive compounds with medicinal properties. Marine environments, covering over 70% of Earth's surface, offer an largely untapped reservoir of biodiversity that holds immense promise for pharmaceutical applications, particularly in areas where terrestrial sources have reached limitations.

The unique environmental conditions of marine habitats, including extreme pressure, temperature variations, and salinity levels, have led marine organisms to develop distinctive metabolic pathways and produce specialized compounds with potential therapeutic benefits. These marine-derived substances have shown remarkable efficacy in treating various conditions including cancer, inflammatory diseases, neurological disorders, and infectious diseases.

As the global healthcare industry continues to seek innovative treatment solutions and faces challenges such as antibiotic resistance and the need for personalized medicine, the marine pharmaceutical market has gained significant attention from researchers, pharmaceutical companies, and investors seeking breakthrough therapeutic discoveries from ocean-based resources.

Market Dynamics

The global marine pharmaceutical market is propelled by several compelling drivers that are reshaping the pharmaceutical landscape and creating unprecedented opportunities for marine-based therapeutic solutions. The increasing prevalence of chronic diseases, including cancer, cardiovascular disorders, and neurological conditions, is driving demand for novel and more effective treatment options, positioning marine pharmaceuticals as a promising alternative to traditional terrestrial-derived medicines.

Growing investment in marine biotechnology research and development, supported by both public and private funding initiatives, is accelerating the discovery and commercialization of marine-derived compounds, while advancing extraction and purification technologies are making it more feasible to develop these complex molecules into viable pharmaceutical products.

However, the market faces significant restraints including the high costs associated with marine exploration, collection, and processing of marine organisms, which can substantially impact the overall development timeline and commercial viability of marine pharmaceutical products. Regulatory complexities surrounding marine pharmaceutical approvals, environmental conservation concerns, and the challenges of sustainable harvesting practices pose additional barriers to market growth.

The technical difficulties in cultivating marine organisms in laboratory settings and scaling up production processes further constrain market expansion. Nevertheless, substantial opportunities exist within this dynamic market landscape, particularly through the untapped potential of deep-sea exploration and the discovery of extremophile organisms that could yield revolutionary pharmaceutical compounds.

Strategic partnerships between pharmaceutical companies and marine research institutions are creating collaborative frameworks for accelerated drug discovery, while technological advancements in synthetic biology and biotechnology are opening new pathways for producing marine-derived compounds through sustainable methods, ultimately positioning the marine pharmaceutical market for significant growth and innovation.

Key Features of the Study

This report provides in-depth analysis of the global marine pharmaceutical market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global marine pharmaceutical market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include PharmaMar SA, Eisai Co Ltd, Pfizer Inc, Takeda Pharmaceutical Company Limited, Seagen Inc, F Hoffmann La Roche Ltd, Astellas Pharma Inc, Jazz Pharmaceuticals plc, RemeGen Co Ltd, Gilead Sciences Inc, Waylis Therapeutics, Teva Pharmaceutical Industries Ltd, Zydus Lifesciences Ltd, Amarin Corporation plc, and Merck KGaA Darmstadt Germany
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global marine pharmaceutical market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global marine pharmaceutical market

Market Segmentation

Source Insights (Revenue, USD Bn, 2020 - 2032)
- Marine invertebrates (sponges, corals, tunicates, mollusks)
- Marine bacteria
- Marine macroalgae (seaweeds)
- Marine microalgae
- Marine fungi
- Marine sediments/extremophiles
- Marine vertebrates (fish, sharks)
Compound Class Insights (Revenue, USD Bn, 2020 - 2032)
- Alkaloids
- Peptides/Proteins
- Polysaccharides
- Lipids/Fatty acids
- Terpenes/Terpenoids
- Sterols
- Enzymes
- Secondary metabolites (unique marine small molecules)
Therapeutic Application Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology/Anticancer agents
- Anti infectives (antibacterial, antiviral, antifungal)
- Anti inflammatory agents
- Cardiovascular drugs
- Neuroprotective/neurological drugs
- Metabolic disorder drugs (diabetes/obesity)
- Pain management/analgesics
- Dermatological agents
- Immunomodulators
Development Stage Insights (Revenue, USD Bn, 2020 - 2032)
- Discovery/bioprospecting
- Preclinical development
- Clinical trials (Phase I-III)
- Approved/Commercialized products
Formulation Type Insights (Revenue, USD Bn, 2020 - 2032)
- Small molecules
- Biologics/biopharmaceuticals
- Extracts/standardized fractions
- Nutraceutical formulations (marine derived)
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Pharma and Biopharma Companies
- Hospitals and Specialty Clinics
- CDMOs/CMOs
- Nutraceutical/functional food producers
- Academic and research institutes
Drug Delivery Format Insights (Revenue, USD Bn, 2020 - 2032)
- Oral
- Injectable/infusion
- Topical/dermal
- Inhalation
- Implants/controlled release
Source Habitat Insights (Revenue, USD Bn, 2020 - 2032)
- Coastal marine
- Deep sea marine
- Polar marine
- Hydrothermal vents/extreme environments
Application Sector Insights (Revenue, USD Bn, 2020 - 2032)
- Human therapeutics
- Veterinary therapeutics
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- PharmaMar SA
- Eisai Co Ltd
- Pfizer Inc
- Takeda Pharmaceutical Company Limited
- Seagen Inc
- F Hoffmann La Roche Ltd
- Astellas Pharma Inc
- Jazz Pharmaceuticals plc
- RemeGen Co Ltd
- Gilead Sciences Inc
- Waylis Therapeutics
- Teva Pharmaceutical Industries Ltd
- Zydus Lifesciences Ltd
- Amarin Corporation plc
- Merck KGaA Darmstadt Germany

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Marine Pharmaceutical Market, By Source
- Global Marine Pharmaceutical Market, By Compound Class
- Global Marine Pharmaceutical Market, By Therapeutic Application
- Global Marine Pharmaceutical Market, By Development Stage
- Global Marine Pharmaceutical Market, By Formulation Type
- Global Marine Pharmaceutical Market, By End User
- Global Marine Pharmaceutical Market, By Drug Delivery Format
- Global Marine Pharmaceutical Market, By Source Habitat
- Global Marine Pharmaceutical Market, By Application Sector
- Global Marine Pharmaceutical Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Marine Pharmaceutical Market, By Source, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Marine invertebrates (sponges, corals, tunicates, mollusks)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Marine bacteria
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Marine macroalgae (seaweeds)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Marine microalgae
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Marine fungi
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Marine sediments/extremophiles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Marine vertebrates (fish, sharks)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Marine Pharmaceutical Market, By Compound Class, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Alkaloids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Peptides/Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Polysaccharides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Lipids/Fatty acids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Terpenes/Terpenoids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Sterols
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Enzymes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Secondary metabolites (unique marine small molecules)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Marine Pharmaceutical Market, By Therapeutic Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oncology/Anticancer agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Antiinfectives (antibacterial, antiviral, antifungal)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Antiinflammatory agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiovascular drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neuroprotective/neurological drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Metabolic disorder drugs (diabetes/obesity)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pain management/analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Dermatological agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Immunomodulators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Marine Pharmaceutical Market, By Development Stage, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Discovery/bioprospecting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Preclinical development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Clinical trials (Phase I-III)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Approved/Commercialized products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Marine Pharmaceutical Market, By Formulation Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Small molecules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Biologics/biopharmaceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Extracts/standardized fractions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Nutraceutical formulations (marinederived)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Marine Pharmaceutical Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pharma and Biopharma Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hospitals and Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
CDMOs/CMOs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Nutraceutical/functional food producers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Academic and research institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Marine Pharmaceutical Market, By Drug Delivery Format, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Injectable/infusion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Topical/dermal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Inhalation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Implants/controlledrelease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Marine Pharmaceutical Market, By Source Habitat, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Coastal marine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Deepsea marine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Polar marine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hydrothermal vents/extreme environments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

12. Global Marine Pharmaceutical Market, By Application Sector, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Human therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Veterinary therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

13. Global Marine Pharmaceutical Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Compound Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Development Stage, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Delivery Format, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Source Habitat, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application Sector, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Compound Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Development Stage, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Delivery Format, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Source Habitat, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application Sector, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Compound Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Development Stage, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Delivery Format, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Source Habitat, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application Sector, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Compound Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Development Stage, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Delivery Format, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Source Habitat, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application Sector, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Compound Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Development Stage, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Delivery Format, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Source Habitat, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application Sector, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Compound Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Development Stage, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Delivery Format, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Source Habitat, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application Sector, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

14. Competitive Landscape

PharmaMar SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Eisai Co Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Seagen Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
F Hoffmann La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Astellas Pharma Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Jazz Pharmaceuticals plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
RemeGen Co Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Gilead Sciences Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Waylis Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Zydus Lifesciences Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Amarin Corporation plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck KGaA Darmstadt Germany
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies